Greenbrook TMS NeuroHealth Centers in Chicago, IL offers FDA-cleared NeuroStar® TMS Therapy and SPRAVATO® (esketamine) as depression treatments. NeuroStar® TMS Therapy is a non-medication option that specifically targets brain areas linked to depression, while SPRAVATO® is a ketamine-based antidepressant. Both treatments are adaptable to fit into existing treatment plans, with no downtime and minimal side effects.
Patients at Greenbrook TMS NeuroHealth Centers benefit from insurance coverage, including Medicare and Medicaid, at multiple locations. The dedicated team works directly with insurance providers to handle paperwork and ensure seamless processing. Patients can explore treatment options through a 1-Minute Quiz to determine suitability for NeuroStar® TMS Therapy or SPRAVATO®.
Individuals struggling with depression can find hope at Greenbrook TMS NeuroHealth Centers. Through innovative treatments like NeuroStar® TMS Therapy and SPRAVATO®, patients can achieve relief even after trying other therapies without success. The Centers offer accessible locations and a compassionate team ready to support those seeking a path towards remission from depression.
Generated from the website content
